Florbetapir 18F ( DrugBank: - )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
127	Frontotemporal lobar degeneration	2

127. Frontotemporal lobar degeneration

---

Clinical trials : 89 /  Drugs : 104 - (DrugBank : 33) / Drug target genes : 40 - Drug target pathways : 117

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01890343 (ClinicalTrials.gov)	September 2009	27/6/2013	Imaging Characteristics of Florbetapir 18F in Patients With Frontotemporal Dementia, Alzheimer's Disease and Normal Controls.	A Study Evaluating the Imaging Characteristics of Florbetapir 18F (18F-AV-45) in Patients With Frontotemporal Dementia Compared to Patients With Alzheimer's Disease and Normal Controls.	Alzheimer's Disease;Frontotemporal Dementia	Drug: florbetapir 18F;Drug: 18F-FDG	Avid Radiopharmaceuticals	NULL	Completed	45 Years	N/A	All	34	Phase 2	United Kingdom
2	EUCTR2008-003597-18-GB (EUCTR)	28/05/2009	14/04/2009	Amyloid imaging in Alzheimer’s disease, frontotemporal dementia and healthy volunteers	A study evaluating the imaging characteristics of 18F-AV-45 in patients with frontotemporal dementia compared to patients with Alzheimer's disease and normal controls	Use of 18F-AV-45 positron emission tomography as early diagnostic technique in frontal lobe dementia and Alzheimer's disease. MedDRA version: 14.0;Level: PT;Classification code 10061816;Term: Diagnostic procedure;System Organ Class: 10022891 - Investigations	Product Name: florbetapir 18F Product Code: 18F-AV-45 Other descriptive name: florbetapir 18F Injection	Avid Radiopharmaceuticals, Inc	NULL	Not Recruiting			Female: yes Male: yes	40	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - (Phase 3): no Therapeutic use (Phase 4): no	United Kingdom